EUVIMEDEUVIMED entdecken
Crossref

Clozapine Treatment for Aggressive Behaviors in Youths with Neurodevelopmental Disorders

Stefano Berloffa, Gabriele Masi, Francesca Falcone, Valerio Simonelli, Antonio Narzisi, Elena Valente, Valentina Viglione, Annarita Milone, Gianluca Sesso iD

Journal of Child and Adolescent Psychopharmacology · 2024-04 · 34 (3) · 148-156

DOI: 10.1089/cap.2023.0097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Child and Adolescent Psychopharmacology, online erschienen am 11.04.2024. Verfasst von Stefano Berloffa und 8 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Stella Maris, Scientific Institute of Child Neurology and Psychiatry, Calambrone, Italy. Hauptthemen laut MEDLINE: Clozapine, Autism Spectrum Disorder, Neurodevelopmental Disorders, Antipsychotic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this study was to assess effectiveness and tolerability of Clozapine in the treatment of aggression in youth with Neurodevelopmental Disorders.

Methods

Patients were consecutively admitted at our third-level university hospital with nationwide catchment from June 2018 to October 2022, and followed up to July 2023. Eligibility criteria were as follows: (1) Autism Spectrum Disorder (ASD) and/or Intellectual Disability/Borderline Cognitive Functioning, (2) behavioral dyscontrol with physical aggression; (3) age range between 8 and 18 years; (4) clinical indication for Clozapine treatment after at least two failed trials with other Second-Generation Antipsychotics (SGAs); (5) availability of an at least 6-month-long follow-up. To evaluate the response to Clozapine, we used the Clinical Global Impressions (CGI) rating scales (Clinical Global Impressions-Severity [CGI-S] and Clinical Global Impressions-Improvement [CGI-I]), the Children's Global Assessment Scale (CGAS), and the Aberrant Behavior Checklist (ABC).

Results

Twenty-six children and adolescents (21 boys, age 13.47 ± 2.05 years, follow-up duration 9.77 ± 3.50 months) were included in the analysis. Clinical severity (CGI-S) and functional impairment (Clinical Global Assessment Scale) significantly improved, as well as the ABC Total Score and the scores in several subscales. Sixteen patients (61.54%) were responders (CGI-I ≤2), and 13 (50.00%) displayed remission of aberrant behaviors (ΔABC-Total >35), while response/remission condition was not affected by add-on medications and psychotherapy. Most frequent side effects were increased appetite (50.00%), sialorrhea (38.46%), and increased repetitive behaviors (26.92%). Two patients presented epileptic seizures, while no patients presented leucopoenia.

Conclusions

Our results suggest that Clozapine may be helpful in ameliorating treatment-resistant aggression in youth with neurodevelopmental conditions. Possible pharmacological strategies for the management of most frequent side effects are also suggested.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineAutism Spectrum DisorderNeurodevelopmental DisordersAntipsychotic AgentsMaleChildHumansAdolescentAggressionPsychotherapy

Stichwörter der Autor:innen

Clozapineadolescentsaggressionautism spectrum disorderchildrenintellectual disability

Substanzen

ClozapineAntipsychotic Agents

Autor:innen und Institutionen

  • IRCCS Stella Maris, Scientific Institute of Child Neurology and Psychiatry, Calambrone, Italy.
  • Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Social and Affective Neuroscience Group, Molecular Mind Lab, IMT School for Advanced Studies Lucca, Lucca, Italy.

ORCID-Profile: Gianluca Sesso

Zitieren

APA

Berloffa, S., Masi, G., Falcone, F., Simonelli, V., Narzisi, A., Valente, E., Viglione, V., Milone, A., & Sesso, G. (2024). Clozapine Treatment for Aggressive Behaviors in Youths with Neurodevelopmental Disorders. Journal of Child and Adolescent Psychopharmacology, 34(3), 148-156. https://doi.org/10.1089/cap.2023.0097

Vancouver

Berloffa S, Masi G, Falcone F, Simonelli V, Narzisi A, Valente E, et al. Clozapine Treatment for Aggressive Behaviors in Youths with Neurodevelopmental Disorders. Journal of Child and Adolescent Psychopharmacology. 2024;34(3):148-156. doi:10.1089/cap.2023.0097

BibTeX
@article{Berloffa2024,
  author = {Berloffa, Stefano and Masi, Gabriele and Falcone, Francesca and Simonelli, Valerio and Narzisi, Antonio and Valente, Elena and Viglione, Valentina and Milone, Annarita and Sesso, Gianluca},
  title = {Clozapine Treatment for Aggressive Behaviors in Youths with Neurodevelopmental Disorders},
  journal = {Journal of Child and Adolescent Psychopharmacology},
  year = {2024},
  volume = {34},
  number = {3},
  pages = {148--156},
  doi = {10.1089/cap.2023.0097}
}
Kostenlos starten →